خانه › سرطان متاستاتیک › تنسی › Nashville
آزمایش‌های بالینی سرطان متاستاتیک در Nashville، TN
70 مطالعه برای سرطان متاستاتیک در مراکز Nashville (در شعاع حدود ۳۰ مایل) در جستجوی شرکت‌کننده هستند. یک مطالعه را باز کنید تا شرایط شرکت و نحوه تماس با تیم پژوهشی را ببینید.
متن رسمی مطالعه (انگلیسی)
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
در حال جذب شرکت‌کنندهمرحله 1/2
- Avenzo Therapeutics Recruiting Site, Nashville
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
در حال جذب شرکت‌کنندهمرحله 3
- Sarah Cannon Research Institute, Nashville
- Tennessee Oncology, Nashville
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
در حال جذب شرکت‌کنندهمرحله 2
- Vanderbilt Breast Center at One Hundred Oaks, Nashville
- Vanderbilt University/Ingram Cancer Center, Nashville
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1
- Tennessee Oncology, Nashville
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1
- Sarah Cannon Research Institute, Nashville
- Tennessee Oncology PLLC, Nashville
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
در حال جذب شرکت‌کنندهمرحله 1/2
- Sarah Cannon Research Institute, Nashville
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
در حال جذب شرکت‌کنندهمرحله 1
- Sarah Cannon Research Institute (SCRI), Nashville
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1
- Sarah Cannon Research Institute (SCRI), Nashville
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1
- SCRI Oncology Partners, Nashville
A Study of ASP3082 in Adults With Advanced Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1
- Vanderbilt University Medical Center, Nashville
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
در حال جذب شرکت‌کنندهمرحله 2/3
- Henry-Joyce Cancer Clinic, Nashville
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
در حال جذب شرکت‌کنندهمرحله 1
- Vanderbilt Breast Center at One Hundred Oaks, Nashville
- Vanderbilt University/Ingram Cancer Center, Nashville
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
در حال جذب شرکت‌کنندهمرحله 3
- Henry-Joyce Cancer Clinic, Nashville
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1
- Sarah Cannon Research Institute, Nashville
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
در حال جذب شرکت‌کنندهمرحله 3
- Research Site, Nashville
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
در حال جذب شرکت‌کنندهمرحله 2/3
- Henry-Joyce Cancer Clinic, Nashville
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1
- SCRI Oncology Partners, Nashville
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
در حال جذب شرکت‌کنندهمرحله 3
- SCRI Oncology Partners, Nashville
- Tennessee Oncology, PLLC-Elliston Place Plaza Medical Oncology &Hematology, Nashville
- Tennessee Oncology, PLLC - Saint Thomas West, Nashville
- و 3 مورد دیگر
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
در حال جذب شرکت‌کنندهمرحله 1/2
- Sarah Cannon Research Institute, Nashville
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
در حال جذب شرکت‌کنندهمرحله 3
- Vanderbilt University Medical Center, Nashville
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
در حال جذب شرکت‌کنندهمرحله 3
- Sarah Cannon Research Institute, Nashville
- SCRI Oncology Partners, Nashville
- Tennessee Oncology, Nashville
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
در حال جذب شرکت‌کنندهمرحله 3
- Sarah Cannon Research Institute SCRI, Nashville
- Nashville General Hospital, Nashville
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1/2
- Sarah Cannon Research Institue, Nashville
AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1
- Tennessee Oncology PLLC, Nashville
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
در حال جذب شرکت‌کنندهمرحله 1/2
- Tennessee Oncology, PLLC, Nashville
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
در حال جذب شرکت‌کنندهمرحله 1/2
- Sarah Cannon Research Institute, Nashville
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
در حال جذب شرکت‌کنندهمرحله 1/2
- Sarah Cannon Research Institute, Nashville
- SCRI Oncology Partners, Nashville
- Tennessee Oncology, PLLC- Elliston Place Plaza, Nashville
- و 11 مورد دیگر
Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1/2
- SCRI Oncology Partners, Nashville
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1/2
- Clinical Study Site, Nashville
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1
- Sarah Cannon Research Center, Nashville
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1
- Sarah Cannon Research Institute, Nashville
- SCRI Oncology Partners, Nashville
- Vanderbilt-Ingram Cancer Center, Nashville
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
در حال جذب شرکت‌کنندهمرحله 3
- Research Site, Nashville
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
در حال جذب شرکت‌کنندهمرحله 3
- Tennessee Oncology, Nashville
- USO - US Oncology Research Network, Nashville
NPX372, a B7-H7:CD3 Bispecific Antibody, in Selected Solid Tumor Malignancies
در حال جذب شرکت‌کنندهمرحله 1
- Sarah Cannon Research Institute, Nashville
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
در حال جذب شرکت‌کنندهمرحله 2
- Vanderbilt Breast Center at One Hundred Oaks, Nashville
- Vanderbilt University/Ingram Cancer Center, Nashville
A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Activity of IPN01203 in Adults With Locally Advanced or Metastatic Solid Tumours Exposed to Immune Checkpoint Inhibitor Therapies
در حال جذب شرکت‌کنندهمرحله 1/2
- Sarah Cannon Research Institute - Tennessee Oncology, Nashville
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1
- Sarah Cannon Research Institute-Tennessee Oncology, Nashville
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
در حال جذب شرکت‌کنندهمرحله 2
- Vanderbilt-Ingram Cancer Center, Nashville
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
در حال جذب شرکت‌کنندهمرحله 1
- Sarah Cannon and HCA Research Institute, Nashville
- Tennessee Oncology, Nashville
- Vanderbilt University Medical Center, Nashville
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
در حال جذب شرکت‌کنندهمرحله 2
- Research Site, Nashville
FOG-001 in Locally Advanced or Metastatic Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1/2
- Sarah Cannon Research Institute, Nashville
- Vanderbilt Ingram Cancer Center, Nashville
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
در حال جذب شرکت‌کنندهمرحله 1/2
- Vanderbilt University/Ingram Cancer Center, Nashville
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1/2
- SCRI Oncology Partners, Nashville
- Vanderbilt Medical Center, Nashville
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
در حال جذب شرکت‌کنندهمرحله 3
- Research Site, Nashville
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1
- Investigative Site #102, Nashville
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1
- SCRI Oncology Partners, Nashville
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1/2
- Sara Cannon Research Institute Tennessee, Nashville
A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1
- Exelixis Clinical Site #3, Nashville
A Study of LY4175408 in Participants With Advanced Cancer
در حال جذب شرکت‌کنندهمرحله 1
- Sarah Cannon Research Institute, Nashville
CT-95 in Advanced Cancers Associated With Mesothelin Expression
در حال جذب شرکت‌کنندهمرحله 1
- Context Investigational Site, Nashville
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
در حال جذب شرکت‌کنندهمرحله 1
- Research Site, Nashville
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1
- Sarah Cannon Research Institute, Nashville
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
در حال جذب شرکت‌کنندهمرحله 1
- Vanderbilt University Medical Center, Nashville
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
در حال جذب شرکت‌کنندهمرحله 1/2
- Sarah Cannon, Nashville
Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)
در حال جذب شرکت‌کنندهمرحله 1/2
- SCRI Oncology Partners, Nashville
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
در حال جذب شرکت‌کنندهمرحله 1/2
- Sarah Cannon Research Institute, Nashville
Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy
در حال جذب شرکت‌کنندهمرحله اول اولیه
- Vanderbilt University Medical Center, Nashville
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1/2
- SCRI Oncology Partners, Nashville
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
در حال جذب شرکت‌کنندهمرحله 2/3
- Sarah Cannon Research Institute, Nashville
- Vanderbilt Ingram Cancer Center (Henry-Joyce Cancer Clinic), Nashville
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1
- SCRI Oncology Partners, Nashville
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
در حال جذب شرکت‌کنندهمرحله 1
- SCRI Oncology Partners, Nashville
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
در حال جذب شرکت‌کنندهمرحله 1
- Sarah Cannon Research Institute (SCRI) Oncology Partners, Nashville
- Vanderbilt University Medical Center, Nashville
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
در حال جذب شرکت‌کنندهمرحله 3
- Vanderbilt University Medical Center, Nashville
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
در حال جذب شرکت‌کنندهمرحله 1
- Urology Associates PC, Nashville
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1
- Vanderbilt-Ingram Cancer Center, Nashville
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1
- SCRI Oncology Partners, Nashville
A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.
در حال جذب شرکت‌کنندهمرحله 1
- Sarah Cannon Research Institute (SCRI) Oncology Partners, Nashville
Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma
در حال جذب شرکت‌کنندهمرحله 1/2
- SCRI Oncology Partners, Nashville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
در حال جذب شرکت‌کنندهمطالعه مشاهده‌ای
- Massive Bio SYNERGY-AI site, Nashville
ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)
در حال جذب شرکت‌کنندهمرحله 1
- Sarah Cannon Research Institute (SCRI) Oncology Partners, Nashville
آزمایش‌های سرطان متاستاتیک در سایر شهرها
- Houston, TX104 مطالعه
- New York City, NY93 مطالعه
- Boston, MA63 مطالعه
- Los Angeles, CA57 مطالعه
- St. Louis, MO54 مطالعه
- Arlington, VA53 مطالعه
- Philadelphia, PA46 مطالعه
- Chicago, IL45 مطالعه
- San Antonio, TX44 مطالعه
- Washington, DC43 مطالعه
- Dallas, TX42 مطالعه
- Seattle, WA39 مطالعه
سایر مطالعات در Nashville
- سرطان ریه غیرسلول کوچک97 مطالعه
- سرطان پستان81 مطالعه
- سرطان کولورکتال69 مطالعه
- سرطان (همه انواع)65 مطالعه
- سرطان تخمدان49 مطالعه
- سرطان پروستات43 مطالعه
- سرطان ریه40 مطالعه
- کارسینوم سلول سنگفرشی سر و گردن39 مطالعه
- سرطان لوزالمعده39 مطالعه
- سرطان آندومتر38 مطالعه
- ملانوم33 مطالعه
- میلوم متعدد32 مطالعه
از ClinicalTrials.gov، داده‌ها در تاریخ 6 اکتبر 2026 دریافت شده است. هر مطالعه شرایط اختصاصی خود را دارد؛ تیم پژوهشی تصمیم می‌گیرد چه کسانی می‌توانند شرکت کنند.